| 1 |
Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol 2019;24:771-8. [PMID: 30980196 DOI: 10.1007/s10147-019-01443-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 2 |
Ding Y, Yang Q, Wang B, Ye G, Tong X. The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0165509. [PMID: 27824946 DOI: 10.1371/journal.pone.0165509] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 3 |
Oue N, Sentani K, Sakamoto N, Yasui W. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype. Cancer Sci. 2015;106:951-958. [PMID: 26033320 DOI: 10.1111/cas.12706] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 4 |
Cho M, Eze O, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet 2014; 4(3): 58-68 [DOI: 10.5496/wjmg.v4.i3.58] [Reference Citation Analysis]
|
| 5 |
Naito Y, Oue N, Hinoi T, Sakamoto N, Sentani K, Ohdan H, Yanagihara K, Sasaki H, Yasui W. Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer. PLoS One. 2012;7:e47545. [PMID: 23133598 DOI: 10.1371/journal.pone.0047545] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 7 |
Lee JS, Fackler MJ, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Sukumar S. Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther. 2010;9:1017-1024. [PMID: 20505321 DOI: 10.4161/cbt.9.12.11804] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 8 |
Oue N, Sentani K, Sakamoto N, Motoshita J, Nishisaka T, Fukuhara T, Matsuura H, Sasaki H, Nakachi K, Yasui W. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors. Int J Cancer 2009;124:1112-21. [PMID: 19058179 DOI: 10.1002/ijc.24060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Khodyrev DS, Loginov VI, Pronina IV, Kazubskaya TP, Garkavtseva RF, Braga EA. Methylation of promoter region of RAR-β2 gene in renal cell, breast, and ovarian carcinomas. Russ J Genet 2008;44:983-8. [DOI: 10.1134/s1022795408080139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Heatley MK. Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis. Histopathology 2008;52:267-76. [DOI: 10.1111/j.1365-2559.2007.02824.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 11 |
Motoshita J, Nakayama H, Taniyama K, Matsusaki K, Yasui W. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. Pathol Int. 2006;56:200-205. [PMID: 16634965 DOI: 10.1111/j.1440-1827.2006.01946.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
